- Global Pharma News & Resources

China VNA and PACS Market by 2023 , it’s expected to have grown at a CAGR of 14.2%: Meticulous Research

A report into the projected growth of the China VNA & PACS market by Meticulous Research® has produced lucrative forecasts for the industry. By 2023, it’s expected to have grown at a CAGR of 14.2%.

Future Outlook: China VNA & PACS market to witness lucrative growth during the forecast period (2018-2023)

The researchers suggest that the growth of China VNA & PACS market will be driven by favorable healthcare reforms, growing economy and disposable income, rising geriatric imaging volumes, growing adoption of advanced medical technologies and health IT, and increasing installation of diagnostic imaging modalities. Moreover, penetration of artificial intelligence in medical imaging, rapidly growing field of telehealth, and adoption of advanced modalities especially in Level III hospitals offer significant growth opportunities for the market players during the forecast period.

Download Complete Free Sample PDF Copy NOW:

The report states that Departmental PACS currently account for the largest share of the total market and is expected to grow at a CAGR of 12.4% from 2018 to 2023. Meticulous Research® identified as to why this segment will continue dominating over enterprise PACS: “significant adoption of PACS in radiology department where majority of the imaging studies are handled, managed, and stored; and rising incorporation of PACS into other specialties such as cardiology, ophthalmology, oncology, endoscopy, teleradiology, dermatology, pathology, neurology, and dentistry.”

Check complete table of contents with list of table and figures :

Based on delivery mode, on premise PACS commanded the largest share. Meticulous Research® identified as to why this segment will continue dominating web/cloud PACS models: “perception of health systems that it provides greater security, control over images and lower latency than cloud storage”. On the other hand, web/cloud PACS models are rapidly gaining traction owing to its low cost of storage and archiving, and offsite data center that manages data backup, disaster protection and recovery.

Hospitals were the leading adopters of PACS and VNA in China and are also expected to register fastest growth during the forecast period. Hospitals are further segmented in to public hospitals and private hospitals. Public hospitals are further segmented into tier I, tier II, and tier III hospitals. Tier III hospitals commanded the largest share of VNA & PACS market in China. Meticulous Research® identified as to why this segment will continue dominating this market: “changing economy and increasing middle class population, advanced specialists and equipment, increasing prevalence of cancer, demand of better healthcare services, public trust towards Level III Hospitals, and access to state-of-the-art technology”.

Make an inquiry for purchasing this report:

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Contact Us:
Meticulous Research®
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Editor Details

Last Updated: 21-Feb-2020